loading
Precedente Chiudi:
$1.33
Aprire:
$1.34
Volume 24 ore:
5.53M
Relative Volume:
2.79
Capitalizzazione di mercato:
$10.94M
Reddito:
-
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-0.2563
EPS:
-5.97
Flusso di cassa netto:
$-28.20M
1 W Prestazione:
+41.67%
1M Prestazione:
+115.16%
6M Prestazione:
-58.42%
1 anno Prestazione:
-90.41%
Intervallo 1D:
Value
$1.3198
$1.79
Intervallo di 1 settimana:
Value
$0.969
$1.79
Portata 52W:
Value
$0.65
$26.25

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name
Nome
Citius Pharmaceuticals Inc
Name
Telefono
(908) 967-6676
Name
Indirizzo
11 COMMERCE DRIVE, CRANFORD, NJ
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-07
Name
Ultimi documenti SEC
Name
CTXR's Discussions on Twitter

Confronta CTXR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CTXR
Citius Pharmaceuticals Inc
1.53 10.94M 0 -39.14M -28.20M -5.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-30 Aggiornamento D. Boral Capital Hold → Buy
2021-11-30 Iniziato Maxim Group Buy

Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie

pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PR Newswire

Jun 17, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Sells 1,126,188 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate

Jun 13, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Closes $6M Securities Offering - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

After Major Oncology Conference, All Eyes Turn to Industry Innovation - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces Closing Of Registered Direct Offering Of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Secures $15.8M Financing Deal: What This Means for LYMPHIR Commercialization - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal

Jun 12, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundrais - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma secures $6 million in stock offering By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundraising Efforts | CTXR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Stock Is Falling Tuesday: What's Going On? - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offeri - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offering - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Price Target Lowered, Rating Maint - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals announces registered direct offering of $15.8 million - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma secures $6 million in stock offering - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offeri - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offering | CTXR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharma Announces Direct Offering - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Given “Buy” Rating at D. Boral Capital - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals expands authorized shares By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals (CTXR) Receives Continued Buy Rating from Analyst | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals expands authorized shares - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? - Benzinga

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Sells 609,711 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Sells 306,583 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - mx.advfn.com

Jun 04, 2025
pulisher
Jun 03, 2025

Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda - TipRanks

Jun 03, 2025
pulisher
May 29, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World

May 29, 2025
pulisher
May 27, 2025

Why Shares of SoundHound AI Are Soaring Today - The Globe and Mail

May 27, 2025
pulisher
May 26, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World

May 26, 2025
pulisher
May 23, 2025

Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN

May 23, 2025
pulisher
May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025
pulisher
May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus

May 23, 2025

Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):